loading
Precedente Chiudi:
$1.59
Aprire:
$1.59
Volume 24 ore:
1.09M
Relative Volume:
1.04
Capitalizzazione di mercato:
$256.87M
Reddito:
$314.00K
Utile/perdita netta:
$-40.23M
Rapporto P/E:
-1.6467
EPS:
-0.92
Flusso di cassa netto:
$-84.71M
1 W Prestazione:
+10.58%
1M Prestazione:
+26.25%
6M Prestazione:
-9.82%
1 anno Prestazione:
+41.59%
Intervallo 1D:
Value
$1.51
$1.60
Intervallo di 1 settimana:
Value
$1.43
$1.95
Portata 52W:
Value
$1.025
$2.85

Atai Life Sciences N V Stock (ATAI) Company Profile

Name
Nome
Atai Life Sciences N V
Name
Telefono
49 89 2153 9035
Name
Indirizzo
WALLSTRASSE 16, BERLIN
Name
Dipendente
83
Name
Cinguettio
Name
Prossima data di guadagno
2024-12-11
Name
Ultimi documenti SEC
Name
ATAI's Discussions on Twitter

Confronta ATAI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ATAI 1.515 256.87M 314.00K -40.23M -84.71M -0.92
VRTX 450.01 115.43B 10.63B -479.80M -1.35B 13.33
REGN 746.02 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 594.70 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 245.85 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 107.66 24.89B 3.30B -501.07M 1.03B 11.54

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-11-01 Iniziato Loop Capital Buy
2021-11-30 Iniziato Maxim Group Buy
2021-11-11 Iniziato ROTH Capital Buy
2021-10-18 Iniziato H.C. Wainwright Buy
2021-09-01 Iniziato Jefferies Buy
2021-07-13 Iniziato Berenberg Buy
2021-07-13 Iniziato Canaccord Genuity Buy
2021-07-13 Iniziato Cantor Fitzgerald Buy
2021-07-13 Iniziato Citigroup Buy
2021-07-13 Iniziato Cowen Outperform
2021-07-13 Iniziato Credit Suisse Outperform
2021-07-13 Iniziato RBC Capital Mkts Sector Perform
2021-07-08 Iniziato Aegis Capital Buy
Mostra tutto

Atai Life Sciences N V Borsa (ATAI) Ultime notizie

pulisher
Nov 19, 2024

Atai Life Sciences stock target cut, retains buy rating on developments - Investing.com

Nov 19, 2024
pulisher
Nov 19, 2024

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch - Simply Wall St

Nov 19, 2024
pulisher
Nov 13, 2024

Atai Life Sciences Advances Psychedelic Treatments in Q3 2024 - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Atai Life Sciences N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024
pulisher
Nov 13, 2024

atai Life Sciences Advances Psychedelic Pipeline as FDA Clears DMT Depression Treatment | ATAI Stock News - StockTitan

Nov 13, 2024
pulisher
Oct 21, 2024

374Water And 2 Other Promising US Penny Stocks To Watch - Simply Wall St

Oct 21, 2024
pulisher
Oct 15, 2024

Are ATAI Life Sciences N.V.’shares a good deal? - US Post News

Oct 15, 2024
pulisher
Oct 15, 2024

Insider Sale Alert: ATAI Life Sciences N.V. [ATAI] – Is it Time to sell? - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan

Oct 15, 2024
pulisher
Oct 11, 2024

Selling Buzz: ATAI Life Sciences N.V. [ATAI] 10% Owner ATAI Life Sciences N.V. sells 2,660,000 shares of the company - Knox Daily

Oct 11, 2024
pulisher
Oct 11, 2024

ATAI Life Sciences N.V. (ATAI)’s results reveal risk - US Post News

Oct 11, 2024
pulisher
Oct 07, 2024

Maxim Group gives a Buy recommendation for ATAI Life Sciences N.V. (ATAI) - Knox Daily

Oct 07, 2024
pulisher
Oct 05, 2024

ATAI Life Sciences completes acquisition of IntelGenx Corp. - Investing.com India

Oct 05, 2024
pulisher
Oct 04, 2024

ATAI Life Sciences completes acquisition of IntelGenx Corp. By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 03, 2024

10% Owner ATAI Life Sciences N.V. sale 2,660,000 shares of ATAI Life Sciences N.V. [ATAI] - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

ATAI Life Sciences N.V. (ATAI) stock analysis: A comprehensive overview - US Post News

Oct 03, 2024
pulisher
Oct 01, 2024

Trading Day Review: ATAI Life Sciences N.V. (ATAI) Loses Momentum, Closing at 1.16 - The Dwinnex

Oct 01, 2024
pulisher
Sep 30, 2024

A History of Outperforming Analyst Forecasts and Beating the Odds: ATAI Life Sciences N.V. (ATAI) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Maxim Group Upgrades ATAI Life Sciences N.V. (ATAI) to a Buy from a Hold - Knox Daily

Sep 30, 2024
pulisher
Sep 28, 2024

Life Sciences N.V. Atai Sells 2,660,000 Shares of COMPASS Pathways plc (NASDAQ:CMPS) Stock - MarketBeat

Sep 28, 2024
pulisher
Sep 27, 2024

Atai Life Sciences executives sell shares valued at $16 million - Investing.com India

Sep 27, 2024
pulisher
Sep 26, 2024

Deeper Dive: Understanding ATAI Life Sciences N.V. (ATAI) Through its Various Ratios - The Dwinnex

Sep 26, 2024
pulisher
Sep 26, 2024

ATAI Life Sciences N.V. (ATAI) deserves closer scrutiny - US Post News

Sep 26, 2024
pulisher
Sep 26, 2024

ATAI Life Sciences N.V. [ATAI] Shares Fall Approximately -7.81% Over the Year - Knox Daily

Sep 26, 2024
pulisher
Sep 23, 2024

TWKS SPECIAL ALERT: Thoughtworks Shareholders Seeking More Than $4.40 Per Share Contact Julie & Holleman Regarding Sale to Apax - PR Newswire

Sep 23, 2024
pulisher
Sep 23, 2024

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Sep 23, 2024
pulisher
Sep 20, 2024

T2 Biosystems Achieves Successful Defense of Patent for - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology - StockTitan

Sep 20, 2024
pulisher
Sep 20, 2024

Magic mushroom market set to go gangbusters, Irish researcher says - Mugglehead

Sep 20, 2024
pulisher
Sep 19, 2024

ATAT’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer (NASDAQ:APLT) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 18, 2024

Athira shifts focus to ALS drug after Alzheimer’s flop - The Pharma Letter

Sep 18, 2024
pulisher
Sep 18, 2024

Australian Clinical Labs Shareholder Stake Shifts - TipRanks

Sep 18, 2024
pulisher
Sep 17, 2024

(ATAT) Trading Advice - Stock Traders Daily

Sep 17, 2024
pulisher
Sep 17, 2024

T2 Biosystems director sells shares worth $133 - Investing.com India

Sep 17, 2024
pulisher
Sep 17, 2024

Atour Lifestyle Holdings Ltd ADR (ATAT) is looking forward to a strong quarter - SETE News

Sep 17, 2024
pulisher
Sep 17, 2024

Atour Lifestyle Holdings Limited (NASDAQ:ATAT) Short Interest Down 8.3% in August - MarketBeat

Sep 17, 2024
pulisher
Sep 17, 2024

Alzheimer’s drug developer Actinogen rattles the tin - The Australian Financial Review

Sep 17, 2024
pulisher
Sep 17, 2024

Substantial Stake Acquired in Australian Clinical Labs - TipRanks

Sep 17, 2024
pulisher
Sep 16, 2024

Cat defies the odds to survive after being born with two faces - MSN

Sep 16, 2024
pulisher
Sep 16, 2024

ATAI Life Sciences N.V. [ATAI] See Remarks makes an insider sale of 151,303 shares worth $0.29 million. - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

T2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric Patients - GlobeNewswire

Sep 16, 2024
pulisher
Sep 13, 2024

Two-faced kitten in Phetchabun leaves locals feline lottery curious - Thaiger

Sep 13, 2024
pulisher
Sep 10, 2024

Monitoring ATAI Life Sciences N.V. (ATAI) after recent insider movements - Knox Daily

Sep 10, 2024
pulisher
Sep 10, 2024

Market Watch Highlights: ATAI Life Sciences N.V. (ATAI) Ends on an Upturn Note at 1.24 - The Dwinnex

Sep 10, 2024
pulisher
Sep 04, 2024

ATAI Life Sciences N.V. [ATAI] Insider Activity: An Update for Investors - Knox Daily

Sep 04, 2024
pulisher
Sep 04, 2024

ATAI Life Sciences N.V. (ATAI)’s stock chart: A technical perspective - US Post News

Sep 04, 2024
pulisher
Sep 04, 2024

atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Sep 04, 2024
pulisher
Sep 04, 2024

Psychedelic Drugs Market to Grow by USD 1.37 Billion from 2024-2028, Driven by Increasing Mental Health Disorders, Report Highlights AI's Impact on the Market LandscapeTechnavio - The Malaysian Reserve

Sep 04, 2024
pulisher
Sep 03, 2024

Psychedelic Stock Deep Dive: Atai Life Sciences (ATAI) (NASDAQ:ATAI) - Seeking Alpha

Sep 03, 2024

Atai Life Sciences N V Azioni (ATAI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):